South Korea
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 49.80 B |
Jan. 14, 2025 | USD 698.37 | 1.93% |
|
South Korea |
|
2 |
USD 26.70 B |
Jan. 14, 2025 | USD 125.83 | 1.12% |
|
South Korea |
|
3 |
USD 12.41 B |
Jan. 14, 2025 | USD 166.75 | 2.20% |
|
South Korea |
|
4 |
USD 11.10 B |
Jan. 14, 2025 | USD 209.72 | 3.60% |
|
South Korea |
|
5 |
USD 6.77 B |
Jan. 14, 2025 | USD 54.15 | 2.28% |
|
South Korea |
|
6 |
USD 6.71 B |
Jan. 14, 2025 | USD 89.21 | -4.31% |
|
South Korea |
|
7 |
USD 5.91 B |
Jan. 14, 2025 | USD 75.63 | -3.02% |
|
South Korea |
|
8 |
USD 5.32 B |
Jan. 14, 2025 | USD 97.87 | 1.09% |
|
South Korea |
|
9 |
USD 2.57 B |
Jan. 14, 2025 | USD 33.55 | -1.07% |
|
South Korea |
|
10 |
USD 2.23 B |
Jan. 14, 2025 | USD 177.66 | 0.74% |
|
South Korea |
|
11 |
USD 1.79 B |
Jan. 14, 2025 | USD 171.86 | 2.57% |
|
South Korea |
|
12 |
USD 1.64 B |
Jan. 14, 2025 | USD 38.12 | 0.02% |
|
South Korea |
|
13 |
USD 1.43 B |
Jan. 14, 2025 | USD 64.52 | 1.38% |
|
South Korea |
|
14 |
USD 1.35 B |
Jan. 14, 2025 | USD 19.95 | 0.05% |
|
South Korea |
|
15 |
USD 1.24 B |
Jan. 14, 2025 | USD 108.37 | -2.33% |
|
South Korea |
|
16 |
USD 1.21 B |
Jan. 14, 2025 | USD 61.65 | 0.74% |
|
South Korea |
|
17 |
USD 1.18 B |
Jan. 14, 2025 | USD 104.35 | -0.50% |
|
South Korea |
|
18 |
USD 1.01 B |
Jan. 14, 2025 | USD 89.82 | -0.84% |
|
South Korea |
|
19 |
USD 981.42 M |
Jan. 14, 2025 | USD 21.07 | 1.40% |
|
South Korea |
|
20 |
USD 959.57 M |
Jan. 14, 2025 | USD 7.85 | -1.23% |
|
South Korea |
|
21 |
USD 917.62 M |
Jan. 14, 2025 | USD 38.94 | 0.04% |
|
South Korea |
|
22 |
USD 850.98 M |
Jan. 14, 2025 | USD 7.36 | 1.21% |
|
South Korea |
|
23 |
USD 829.74 M |
Jan. 14, 2025 | USD 64.45 | 0.31% |
|
South Korea |
|
24 |
USD 789.87 M |
Jan. 14, 2025 | USD 17.02 | -2.20% |
|
South Korea |
|
25 |
USD 669.02 M |
Jan. 14, 2025 | USD 17.25 | 0.74% |
|
South Korea |
|
26 |
USD 649.29 M |
Jan. 14, 2025 | USD 4.13 | 2.75% |
|
South Korea |
|
27 |
USD 597.25 M |
Jan. 14, 2025 | USD 7.02 | 1.13% |
|
South Korea |
|
28 |
USD 567.51 M |
Jan. 14, 2025 | USD 13.98 | -3.04% |
|
South Korea |
|
29 |
USD 538.20 M |
Jan. 14, 2025 | USD 83.61 | 0.82% |
|
South Korea |
|
30 |
USD 490.98 M |
Jan. 14, 2025 | USD 28.71 | -0.56% |
|
South Korea |
|
31 |
USD 466.94 M |
Jan. 14, 2025 | USD 10.34 | -1.02% |
|
South Korea |
|
32 |
USD 460.27 M |
Jan. 14, 2025 | USD 24.38 | 0.88% |
|
South Korea |
|
33 |
USD 456.99 M |
Jan. 14, 2025 | USD 10.59 | -0.10% |
|
South Korea |
|
34 |
USD 427.46 M |
Jan. 14, 2025 | USD 7.70 | -1.01% |
|
South Korea |
|
35 |
USD 415.22 M |
Jan. 14, 2025 | USD 68.20 | 0.14% |
|
South Korea |
|
36 |
USD 411.29 M |
Jan. 14, 2025 | USD 9.81 | 0.60% |
|
South Korea |
|
37 |
USD 374.62 M |
Jan. 14, 2025 | USD 16.03 | -1.15% |
|
South Korea |
|
38 |
USD 369.97 M |
Jan. 14, 2025 | USD 7.51 | 2.04% |
|
South Korea |
|
39 |
USD 367.44 M |
Jan. 14, 2025 | USD 16.30 | -3.69% |
|
South Korea |
|
40 |
USD 349.48 M |
Jan. 14, 2025 | USD 5.79 | -4.44% |
|
South Korea |
|
41 |
USD 330.23 M |
Jan. 14, 2025 | USD 12.88 | 0.37% |
|
South Korea |
|
42 |
USD 326.94 M |
Jan. 14, 2025 | USD 42.83 | 0.90% |
|
South Korea |
|
43 |
USD 326.10 M |
Jan. 14, 2025 | USD 36.83 | -2.69% |
|
South Korea |
|
44 |
USD 320.65 M |
Jan. 14, 2025 | USD 26.36 | -7.63% |
|
South Korea |
|
45 |
USD 305.47 M |
Jan. 14, 2025 | USD 8.48 | -0.62% |
|
South Korea |
|
46 |
USD 299.66 M |
Jan. 14, 2025 | USD 10.90 | 0.42% |
|
South Korea |
|
47 |
USD 265.40 M |
Jan. 14, 2025 | USD 26.12 | -1.82% |
|
South Korea |
|
48 |
USD 261.31 M |
Jan. 14, 2025 | USD 1.45 | 1.70% |
|
South Korea |
|
49 |
USD 258.15 M |
Jan. 14, 2025 | USD 12.09 | 2.36% |
|
South Korea |
|
50 |
USD 256.29 M |
Jan. 14, 2025 | USD 11.69 | 2.23% |
|
South Korea |
The Pharmaceuticals company in South Korea with the highest Market Capitalization is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 49.80 B.
The Pharmaceuticals company in South Korea with the lowest Market Capitalization is Gencurix Inc. (KOSDAQ: 229000.KQ) at USD 18.54 M.
The top 10 Pharmaceuticals companies in South Korea by Market Capitalization are Samsung Biologics Co.,Ltd., Celltrion, Inc., LG Chem, Ltd., ALTEOGEN Inc., HLB Co., Ltd., Yuhan Corporation, SK Biopharmaceuticals Co., Ltd., SK Inc., SK bioscience Co.,Ltd. and Hanmi Pharm. Co., Ltd..
The bottom 10 Pharmaceuticals companies in South Korea by Market Capitalization are Gencurix Inc., PCL, Inc., Metalabs Co., Ltd., BCWORLD PHARM. Co., Ltd., Wooridul Huebrain Limited, MYUNGMOON Pharm co.,Ltd, Ildong Holdings Co., Ltd., Yuyu Pharma, Inc., Cosmax BTI, Inc. and PharmGen Science, Inc..